Smooth Drug Development offers services to gather information about pharmaceuticals after registration.
Post-marketing research may be required (eg, pharmacovigilance and risk management plans) or initiated by the Marketing authorization holder (such as observational programs, registries and patient support programs).
The data obtained in real world usage can help in planning development in the new indications, get more information contained in the Patient leaflet, identify features of its use in certain groups of patients, drug interactions, treatment regimens.
Our company offers:
- Observational Programs
- Risk Management Programs (RMP)
- Patient Support Programs (PSP)
- Registries of Patients
Smooth Drug Development provides services on post-registration support for pharmaceutical products since 2013.